Lataa...
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
Multiple myeloma is a complex hematologic malignancy, and despite a survival improvement related to the growing number of available therapeutic options since 2000s, it remains an incurable disease with most patients experiencing relapse. However, therapeutic options for this disease are constantly e...
Tallennettuna:
| Julkaisussa: | Pharmaceuticals (Basel) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7760536/ https://ncbi.nlm.nih.gov/pubmed/33260960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120426 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|